Yun‐Yuan Chen, Chi‐Ling Chen, Jen‐Wei Chen, Nien‐Tzu Hsu, Sheng‐Tang Wei, Sheng‐Mou Hou, Sheng‐Nan Lu, Pei‐Jer Chen – 4 June 2020 – The prevalence of hepatitis C virus (HCV) infection in Taiwan was approximately 4% a decade ago, much higher than the worldwide average. This study aimed to assess the HCV burden among 4 million voluntary blood donors after 2 decades of prevention and treatment policies. We retrieved screening results for anti‐HCV and HCV RNA from the Database for Evaluating Voluntary Taiwanese Eligible Donors.

John M. Vierling, Nanda Kerkar, Albert J. Czaja, Cara L. Mack, David Adams, David N. Assis, Michael P. Manns, Marlyn J. Mayo, Tarek Nayfeh, Abdul Mounaem M. Majzoub, Muayad A. Alzuabi, Jingyi Ding, Samir Haffar, M. Hassan Murad, Mouaz Alsawas – 4 June 2020

Anil Prabhu, Tamsin Cargill, Nia Roberts, John D. Ryan – 4 June 2020

Luca Fabris, Keisaku Sato, Gianfranco Alpini, Mario Strazzabosco – 4 June 2020

Sandra Steensels, Jixuan Qiao, Yanzhen Zhang, Kristal M. Maner‐Smith, Nourhan Kika, Corey D. Holman, Kathleen E. Corey, W. Clay Bracken, Eric A. Ortlund, Baran A. Ersoy – 4 June 2020

Meghan E. Sise, Ian Strohbehn, Donald Chute, Kathleen E. Corey, Dahlene N. Fusco, Venkata S Sabbisetti, Sushrut S. Waikar, Raymond T. Chung – 4 June 2020 – Direct‐acting antiviral therapies (DAAs) may improve kidney function and proteinuria in certain patients with hepatitis C infection (HCV) and chronic kidney disease (CKD).

John M. Vierling, Nanda Kerkar, Albert J. Czaja, Cara L. Mack, David Adams, David N. Assis, Michael P. Manns, Marlyn J. Mayo, Tarek Nayfeh, Abdul Mounaem M. Majzoub, Muayad A. Alzuabi, Jingyi Ding, Samir Haffar, M. Hassan Murad, Mouaz Alsawas – 4 June 2020

Karan Kumar, Anand Kulkarni – 3 June 2020

Keyur Patel, Chuhan Chung, Robert P. Myers – 3 June 2020

Dimitrios Patoulias, Alexandra Katsimardou, Christodoulos Papadopoulos, Michael Doumas – 3 June 2020